| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |